Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

CVS Health Corp., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable 15,892 15,713 14,416 13,717 14,897 14,874 13,367 12,527 14,838 13,925 13,238 12,738 12,544 12,696 11,052 10,804 11,138 11,677 9,919 10,223
Pharmacy claims and discounts payable 24,166 23,917 24,188 22,289 22,874 21,497 20,417 20,047 19,423 19,161 18,393 18,572 17,330 17,895 17,225 16,282 15,795 15,722 15,541 15,449
Health care costs payable 15,064 15,237 13,885 14,368 12,049 12,550 11,998 10,895 10,406 10,351 10,400 10,260 8,808 8,877 8,414 8,272 7,936 7,593 7,362 7,585
Accrued expenses and other current liabilities 20,810 21,087 22,214 23,431 23,515 24,011 24,242 22,941 20,245 21,065 19,356 20,757 21,971 20,584 19,394 18,752 18,513 18,293 19,270 16,684
Other insurance liabilities 1,183 1,051 1,041 1,158 1,141 4,748 4,866 4,974 1,140 4,561 1,197 1,387 1,303 1,287 1,375 1,534 1,557 1,527 1,644 1,774
Current portion of operating lease liabilities 1,751 1,912 1,911 1,906 1,741 1,741 1,706 1,679 1,678 1,687 1,854 1,849 1,646 1,809 1,791 1,786 1,638 1,789 1,766 1,762
Short-term debt 2,119 800 2,719 200 1,000 252 255
Current portion of long-term debt 3,624 4,910 3,731 3,731 2,772 2,132 1,402 1,778 1,778 1,363 4,019 4,217 4,205 1,561 60 2,422 5,440 5,443 8,192 5,828
Liabilities held for sale 208 213 228 296
Current liabilities 84,609 84,627 81,386 83,319 79,189 81,553 79,206 75,054 69,736 72,409 68,457 69,780 67,807 64,709 59,311 60,104 62,017 62,044 63,694 59,560
Long-term operating lease liabilities, excluding current portion 14,899 15,258 15,537 15,742 16,034 16,441 16,609 16,571 16,800 17,174 17,502 17,786 18,177 18,456 18,509 18,587 18,757 18,489 18,612 18,739
Long-term debt, excluding current portion 60,527 59,824 62,643 57,694 58,638 59,782 61,419 56,450 50,476 50,848 50,797 52,063 51,971 56,832 59,294 59,270 59,207 61,552 63,481 65,735
Deferred income taxes 3,806 3,632 4,052 4,184 4,311 4,250 4,588 4,095 3,880 3,508 5,450 5,829 6,270 6,329 6,557 6,610 6,794 7,253 7,136 7,121
Separate accounts liabilities 3,311 3,334 3,187 3,271 3,250 3,200 3,267 3,231 3,228 3,318 4,140 4,670 5,087 5,086 4,880 4,692 4,881 4,793 4,639 4,555
Other long-term insurance liabilities 4,902 5,162 5,039 5,178 5,459 5,333 5,659 5,678 6,108 6,175 6,287 6,363 6,402 6,551 6,734 6,870 7,007 7,135 7,270 7,338
Other long-term liabilities 5,431 5,484 5,526 6,205 6,211 6,237 6,321 6,671 6,732 6,769 2,140 2,242 1,904 2,310 2,314 2,309 2,351 2,520 2,308 2,117
Long-term liabilities 92,876 92,694 95,984 92,274 93,903 95,243 97,863 92,696 87,224 87,792 86,316 88,953 89,811 95,564 98,288 98,338 98,997 101,742 103,446 105,605
Total liabilities 177,485 177,321 177,370 175,593 173,092 176,796 177,069 167,750 156,960 160,201 154,773 158,733 157,618 160,273 157,599 158,442 161,014 163,786 167,140 165,165
Preferred stock, par value $0.01; none issued or outstanding
Common stock, par value $0.01, and capital surplus 49,661 49,510 49,371 49,209 48,992 48,829 48,649 48,306 48,193 48,047 47,874 47,677 47,377 47,133 46,995 46,727 46,513 46,388 46,276 46,180
Treasury stock, at cost (36,818) (36,813) (36,919) (36,773) (33,838) (33,831) (33,933) (33,802) (31,858) (30,326) (30,412) (30,145) (28,173) (28,166) (28,252) (28,102) (28,178) (28,164) (28,235) (28,182)
Retained earnings 62,837 62,038 62,797 61,873 61,604 60,343 58,868 57,753 56,145 54,571 58,710 56,488 54,906 54,264 53,331 51,203 49,640 49,328 48,768 46,455
Accumulated other comprehensive income (loss) (120) 209 (319) (341) (297) (1,004) (858) (875) (1,465) (1,609) (988) (190) 965 1,077 1,170 1,022 1,414 1,255 1,213 687
Total CVS Health shareholders’ equity 75,560 74,944 74,930 73,968 76,461 74,337 72,726 71,382 71,015 70,683 75,184 73,830 75,075 74,308 73,244 70,850 69,389 68,807 68,022 65,140
Noncontrolling interests 170 162 181 182 175 173 276 198 300 328 322 310 306 310 321 314 312 305 333 334
Total shareholders’ equity 75,730 75,106 75,111 74,150 76,636 74,510 73,002 71,580 71,315 71,011 75,506 74,140 75,381 74,618 73,565 71,164 69,701 69,112 68,355 65,474
Total liabilities and shareholders’ equity 253,215 252,427 252,481 249,743 249,728 251,306 250,071 239,330 228,275 231,212 230,279 232,873 232,999 234,891 231,164 229,606 230,715 232,898 235,495 230,639

Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. CVS Health Corp. current liabilities increased from Q2 2024 to Q3 2024 but then slightly decreased from Q3 2024 to Q4 2024.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. CVS Health Corp. long-term liabilities decreased from Q2 2024 to Q3 2024 but then slightly increased from Q3 2024 to Q4 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. CVS Health Corp. total liabilities decreased from Q2 2024 to Q3 2024 but then increased from Q3 2024 to Q4 2024 exceeding Q2 2024 level.
Total CVS Health shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. CVS Health Corp. total CVS Health shareholders’ equity increased from Q2 2024 to Q3 2024 and from Q3 2024 to Q4 2024.